The activist fund is putting up four dissident director candidates to the company's board as part of a skirmish over the Mr. Coffee maker's divestiture plans.
Novartis' deal for AveXis has ignited a rally in other gene-therapy concerns.
Stock markets are seeing bigger fluctuations this year amid speculation over signs of accelerating inflation, the pace of Federal Reserve rate increases and U.S. trade tensions with China. That's a relief for JPMorgan and other Wall Street firms following a bout of unusually calm -- and less lucrative -- trading conditions in 2017.
How to trade the highly unlikely deal between Sprint and T-Mobile.
A look at possible second-quarter M&A activity in the biotech sector.
PayPal is accepted at 79% of the top 500 U.S. internet retailers. Its next biggest competitor, Amazon Pay, is only at 12% of retailers.
Two failed bounces this year have made it tougher for stocks to build strong sustained momentum.
The buyout firm is among the final bidders for the rent-to-own retailer. It joins private equity firm Vintage Capital, which The Deal has learned has raised outside funding for its bid.
With LionTree as an adviser and activist Glenn Welling on a key subcommittee exploring strategic alternatives, a sale of the set-top box and interactive digital TV guide company is a serious possibility.
Paying for healthcare costs could be among your biggest concerns after retiring. Here's how the possible tie-in might change the way you access care.
A sale of the rent-to-own retailer is likely to be announced in a month or two, people familiar with the situation said.
The world's largest retailer is reportedly interested in doling out $1 billion for a pharmaceutical fulfillment startup.
It's a new day for the markets following yesterday's selloff. Here are the stories that must be on your radar.
Better-than-expected earnings will help soothe market jitters in the second quarter.
Berkshire's cash hoard has grown to an astounding $116 billion.